Has Lynas Corporation Limited been thrown a lifeline?

Rare earths miner goes into trading halt pending announcement of an integrated funding package

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rare earths producer Lynas Corporation Limited (ASX: LYC) may have saved itself from the chopping block, with an integrated refinancing package expected to be announced by this Friday.

The company went into a trading halt today, and will remain in place until the earlier of the company making the announcement or the commencement of trading on Friday, September 26.

Shareholders may be leaping for joy at that news, but it may not all be great. It's likely that Lynas has secured debt funding for at least part of existing capital, but there may be a nasty sting in the tail – a discounted equity raising to go along with it. The company's bankers may well have figured, "if we're taking a risk, so should shareholders".

It could also be a case of a large investor being allocated a cornerstone equity shareholding in the company – which could see a huge increase in the number of shares on issue – diluting existing shareholders' holdings in the rare earths producer.

So the company may have snagged a lifeline, but it might not be good news for shareholders, and it may only be a temporary reprieve. In May this year, the company said it had enough cash to continue operating for 12 months, even before a $40 million capital raising.

Lynas' biggest issues are production costs that are well above the current prices for rare earth oxides (REO), and prices for REO are at or near multi-year lows. Until the company can scale up production, and reduce its all-in costs to below the current commodity prices it is receiving, investors will likely be on tenterhooks. To do that, Lynas needs to spend cash on production, not on repaying debt.

One of the company's current debt facilities – for US$225 million, requires six-monthly repayments of principal – with US$35 million due this month. Lynas had been hoping to extend the terms of this facility to one repayment of principal in 2016.

But the principal problem remain – too high production costs and too low REO prices. Lynas only has control over the former – it remains to be seen whether the producer can bring those costs enough below REO prices to generate enough cash flow to repay its debts and survive.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »